论文部分内容阅读
目的观察埃索美拉唑钠(耐信)联合立止血治疗上消化道出血的临床疗效。方法将我科收治的87例上消化道出血患者随机分为观察组45例和对照组42例,观察组给予耐信30mg静脉注射,2次/d,同时给予立止血1KU静脉注射,2次/d,连用3d;对照组则给予雷尼替丁0.15g静脉注射,2次/d;垂体后叶素0.2～0.4U/min静脉滴注,连用3d,比较两组的临床疗效。结果观察组总有效率为97.8,明显高于对照组(81.0),差异有统计学意义(P<0.05)。结论埃索美拉唑钠(耐信)联合立止血治疗上消化道出血具有很好的疗效。
Objective To observe the clinical efficacy of esomeprazole sodium (resistant to credit) combined with anti-hemostasis in the treatment of upper gastrointestinal bleeding. Methods A total of 87 cases of upper gastrointestinal bleeding admitted to our department were randomly divided into observation group (n = 45) and control group (n = 42). The observation group was given 30mg intravenous injection of bengxin for 2 times a day, / d, continuous use of 3d; control group was given ranitidine 0.15g intravenous injection, 2 times / d; vasopressin 0.2 ~ 0.4U / min intravenous infusion, even 3d, the clinical efficacy of the two groups were compared. Results The total effective rate of the observation group was 97.8, which was significantly higher than that of the control group (81.0), the difference was statistically significant (P <0.05). Conclusion Esomeprazole sodium (resistant to credit) combined with anti-hemostatic treatment of upper gastrointestinal bleeding has a good effect.